AF
AZN icon

Alerus Financial’s AstraZeneca AZN Stock Holding History

Alerus Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-909
Closed -$167K – 514
2025
Q4 		$167K Sell
909
-13
-1% -$2.28K 0.01% 176
2025
Q3 		$141K Buy
922
+616
+201% +$93.2K 0.01% 197
2025
Q2 		$42.8K Buy
+306
New +$42.9K ﹤0.01% 259

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Alerus Financial's AZN Position: Q1 2026 in Review

Alerus Financial sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 909 shares — an estimated $167K sold.

Alerus Financial first reported a position in AZN in Q2 2025 and held it in 3 quarters. The position peaked at $167K in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Alerus Financial reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Alerus Financial sold 909 AstraZeneca shares in Q1 2026, an estimated $167K.
  • Alerus Financial first reported a position in AstraZeneca in Q2 2025 and held it in 3 quarters.
  • Alerus Financial's AstraZeneca position peaked at $167K in Q4 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.